Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
11/2005
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1030653B1 Dinitroaniline liposomal formulations and processes for their preparation
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/09/2005CN1226406C Attenuated live neospora vaccine
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962987 Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962915 Antiinflammatory agents
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103014A1 2,4-dioxo-5-(2-hydroxy-3,5-dichloro-benzylidene)imino-1,3-pyrimidine salts
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005US20050245600 Novel antimalarial agent
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245469 Crystal forms of azithromycin
11/03/2005US20050244447 Novel drug dosing regimen
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005CA2564570A1 Use of c-kit inhibitors for treating plasmodium related diseases
11/02/2005EP1590360A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005CN1692120A Inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005CN1692104A Benzotriazol-1-yl-amnioacetonitrile compounds and their use in the control of parasite disease
11/02/2005CN1690051A Novel azoles having an insecticidal action
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005100370A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239730 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/27/2005US20050239720 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005CA2564878A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1588714A2 Adjuvant systems and vaccines
10/26/2005EP1587517A1 Anti-protozoal compositions comprising diclazuril
10/26/2005CN1688543A Furanone derivatives and methods of making same
10/26/2005CN1688193A Mixed compositions for controlling parasitic insects
10/26/2005CN1224704C Preparing method for recombinant chBJSTWO protein
10/26/2005CN1224419C Orally administered peptides to ameliorate a therosclerosis
10/26/2005CN1224391C Endoparasiticidal combination
10/25/2005US6958358 Inhibitors of cruzipain and other cysteine proteases
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958235 Recombinant protein containing a C-terminal fragment of plasmodium MSP-1
10/25/2005CA2359708C Ketolide antibiotics
10/20/2005WO2005097816A1 Avermectin and avermectin monosaccharide substituted in the 4”- and 4’- position respectively
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683405A Clonorichis sinensis II 14-3-3 protein, its coded nucleic acid and its use
10/19/2005CN1683404A Clonorichis sinensis ubiquitin homogenetic protein, its coded nucleic acid and its use
10/19/2005CN1683403A Japanese blood fluke cell periodic static agent, its coded nucleic acid and its use
10/19/2005CN1683402A Clonorichis sinensis annexin, its coded nucleic acid and its use
10/19/2005CN1683401A Clonorchis sinensis GTP bindin alpha subunit, its coded nucleic acid and its use
10/19/2005CN1683317A Ester compound of thymol and/or carvacrol, preparing method and its medicinal active composition
10/19/2005CN1682893A External parasite preventing and treating agent for aquatic product animals and its preparing method
10/19/2005CN1682813A Chinese medicine solution agent for treating damp-heat disease and its preparing method
10/19/2005CN1223344C Parasiticides for farmed fish
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/15/2005CA2738682A1 Soft gel delivery system for treating poultry
10/13/2005WO2005095330A1 Novel dichloropropene derivatives
10/13/2005WO2005014654A3 Product comprising a c4bp core protein and a monomeric antigen, and its use
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050227970 3-Benzyl-2-(4-trifluoromethyl-3-pyridylcarbonyl)imino-4-thiazolidone; durability; low concentrations; good spectrum of action; insecticides; miticides; nematocides; helminths
10/13/2005US20050227280 Proteases
10/13/2005US20050226897 Method of protecting against coccidiosis
10/12/2005EP1511510B1 Use of uk114 in the treatment of leishmaniasis
10/12/2005CN1681771A 4-(3, 3-dihalo-allyloxy)phenoxy alkyl derivatives
10/12/2005CN1681529A Immunogenic compositions and diagnostic and therapeutic uses thereof
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1679554A Venous injection of secnidazole
10/12/2005CN1679553A Tinidazole powdery injection and preparation thereof
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222276C Albendazole lipid and method for preparing said lipid by neutralization method
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/06/2005WO2005092329A1 Topical and intravaginal microbicidal antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 218